8JOG

solution structure of Ras Binding Domein (RBD) in C-RAF with negative allosteric modulator.

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.3 mM [U-100% 13C; U-100% 15N] Serin/threonine protein kinase C-RAF, 25 mM sodium phosphate, 50 mM sodium chloride, 10 mM magnesium dichloride	90% H2O/10% D2O	85 mM	6.8	ambient atm	298	Bruker AVANCE III 600
11	2D 1H-13C HSQC aliphatic	0.3 mM [U-100% 13C; U-100% 15N] Serin/threonine protein kinase C-RAF, 25 mM sodium phosphate, 50 mM sodium chloride, 10 mM magnesium dichloride	90% H2O/10% D2O	85 mM	6.8	ambient atm	298	Bruker AVANCE III 600
14	2D 1H-13C HSQC aromatic	0.3 mM [U-100% 13C; U-100% 15N] Serin/threonine protein kinase C-RAF, 25 mM sodium phosphate, 50 mM sodium chloride, 10 mM magnesium dichloride	90% H2O/10% D2O	85 mM	6.8	ambient atm	298	Bruker AVANCE III 600
2	3D CBCA(CO)NH	0.3 mM [U-100% 13C; U-100% 15N] Serin/threonine protein kinase C-RAF, 25 mM sodium phosphate, 50 mM sodium chloride, 10 mM magnesium dichloride	90% H2O/10% D2O	85 mM	6.8	ambient atm	298	Bruker AVANCE III 600
6	3D HNCACB	0.3 mM [U-100% 13C; U-100% 15N] Serin/threonine protein kinase C-RAF, 25 mM sodium phosphate, 50 mM sodium chloride, 10 mM magnesium dichloride	90% H2O/10% D2O	85 mM	6.8	ambient atm	298	Bruker AVANCE III 600
4	3D HNCA	0.3 mM [U-100% 13C; U-100% 15N] Serin/threonine protein kinase C-RAF, 25 mM sodium phosphate, 50 mM sodium chloride, 10 mM magnesium dichloride	90% H2O/10% D2O	85 mM	6.8	ambient atm	298	Bruker AVANCE III 600
7	3D HN(CO)CA	0.3 mM [U-100% 13C; U-100% 15N] Serin/threonine protein kinase C-RAF, 25 mM sodium phosphate, 50 mM sodium chloride, 10 mM magnesium dichloride	90% H2O/10% D2O	85 mM	6.8	ambient atm	298	Bruker AVANCE III 600
5	3D HNCO	0.3 mM [U-100% 13C; U-100% 15N] Serin/threonine protein kinase C-RAF, 25 mM sodium phosphate, 50 mM sodium chloride, 10 mM magnesium dichloride	90% H2O/10% D2O	85 mM	6.8	ambient atm	298	Bruker AVANCE III 600
13	3D HN(CA)CO	0.3 mM [U-100% 13C; U-100% 15N] Serin/threonine protein kinase C-RAF, 25 mM sodium phosphate, 50 mM sodium chloride, 10 mM magnesium dichloride	90% H2O/10% D2O	85 mM	6.8	ambient atm	298	Bruker AVANCE III 600
12	3D 1H-15N NOESY	0.3 mM [U-100% 13C; U-100% 15N] Serin/threonine protein kinase C-RAF, 25 mM sodium phosphate, 50 mM sodium chloride, 10 mM magnesium dichloride	90% H2O/10% D2O	85 mM	6.8	ambient atm	298	Bruker AVANCE III 600
8	3D 1H-13C NOESY aliphatic	0.3 mM [U-100% 13C; U-100% 15N] Serin/threonine protein kinase C-RAF, 25 mM sodium phosphate, 50 mM sodium chloride, 10 mM magnesium dichloride	90% H2O/10% D2O	85 mM	6.8	ambient atm	298	Bruker AVANCE III 600
9	3D 1H-13C NOESY aromatic	0.3 mM [U-100% 13C; U-100% 15N] Serin/threonine protein kinase C-RAF, 25 mM sodium phosphate, 50 mM sodium chloride, 10 mM magnesium dichloride	90% H2O/10% D2O	85 mM	6.8	ambient atm	298	Bruker AVANCE III 600
10	3D HCCH-TOCSY	0.3 mM [U-100% 13C; U-100% 15N] Serin/threonine protein kinase C-RAF, 25 mM sodium phosphate, 50 mM sodium chloride, 10 mM magnesium dichloride	90% H2O/10% D2O	85 mM	6.8	ambient atm	298	Bruker AVANCE III 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	20
Conformers Calculated Total Number	20
Conformers Submitted Total Number	20
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	MagRO-NMRView		Kobayashi et al.
2	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
3	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
4	peak picking	MagRO-NMRView		Kobayashi et al.
5	processing	nmrp

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.